Effects of prior apparatus experience and novelty of testing environment on locomotor activity following MK-801. 2002

A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
Department of Psychology, Montana State University, Bozeman, MT 59717, USA. upymb@montana.edu

Robust increases in locomotor activity are observed following administration of dizocilpine maleate (MK-801). The present study investigated the effects of prior apparatus experience and manipulation of the testing environment on locomotor activity following peripheral MK-801. Gerbils were given zero or nine sessions of apparatus exposure prior to testing with MK-801 (0.1 mg/kg ip) or saline. Sessions were 10 min in duration and separated by 24 h. As previously reported, naive animals treated with MK-801 were significantly more active relative to controls. Exposure to the apparatus for nine sessions resulted in a significant reduction in MK-801-induced activity, but did not alter the activity levels of control animals. To evaluate the effect of changes to the testing environment, animals previously evaluated in the familiar condition were retested in the identical apparatus relocated to a novel experimental room. MK-801-treated animals exhibited a significant increase in activity when tested in this novel environment while the locomotor activity of control gerbils was not significantly altered. The results illustrate the importance of repetitive testing and environmental changes as moderating variables in studies that evaluate locomotor activity. These data also indicate that the effects of MK-801 on activity are sensitive to prior experience with the apparatus and the novelty of the testing environment.

UI MeSH Term Description Entries
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D004777 Environment The external elements and conditions which surround, influence, and affect the life and development of an organism or population. Environmental Impact,Environmental Impacts,Impact, Environmental,Impacts, Environmental,Environments
D005849 Gerbillinae A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. Gerbils,Jird,Meriones,Psammomys,Rats, Sand,Gerbil,Jirds,Merione,Rat, Sand,Sand Rat,Sand Rats
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors
D016291 Dizocilpine Maleate A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects. Dizocilpine,MK-801,MK 801,MK801
D018691 Excitatory Amino Acid Antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. Amino Acids, Excitatory, Antagonists,Excitatory Amino Acid Antagonist,Glutamate Antagonist,Glutamate Antagonists,Glutamate Receptor Antagonist,Amino Acid Antagonists, Excitatory,Antagonists, Excitatory Amino Acid,EAA Antagonists,Glutamate Receptor Antagonists,Antagonist, Glutamate,Antagonist, Glutamate Receptor,Antagonists, EAA,Antagonists, Glutamate,Antagonists, Glutamate Receptor,Receptor Antagonist, Glutamate,Receptor Antagonists, Glutamate

Related Publications

A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
January 1998, Pharmacology, biochemistry, and behavior,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
June 1991, Pharmacology, biochemistry, and behavior,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
March 1997, Behavioural brain research,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
January 2010, Physiology & behavior,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
June 1994, Alcoholism, clinical and experimental research,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
March 1999, Pharmacology, biochemistry, and behavior,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
July 2023, Biochemical and biophysical research communications,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
August 1994, Alcoholism, clinical and experimental research,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
June 1998, Psychopharmacology,
A Michael Babcock, and J Wright, and D Bjerkness, and H Hartman, and N Tall Bear
January 1991, Polish journal of pharmacology and pharmacy,
Copied contents to your clipboard!